サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：髄膜炎診断検査の世界市場 - 市場シェア、規模、動向、業界分析：検査タイプ別、最終用途別、地域別、セグメント予測（2023年～2032年）
市場調査レポート
商品コード
1191455

髄膜炎診断検査の世界市場 - 市場シェア、規模、動向、業界分析：検査タイプ別、最終用途別、地域別、セグメント予測（2023年～2032年）

Meningitis Diagnostic Testing Market Share, Size, Trends, Industry Analysis Report, By Test Type (Latex Agglutination Test, Lateral Flow Assay, PCR Assay, ELISA Test, Culture Test); By End Use; By Region; Segment Forecast, 2023 - 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 117 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.98円
髄膜炎診断検査の世界市場 - 市場シェア、規模、動向、業界分析：検査タイプ別、最終用途別、地域別、セグメント予測（2023年～2032年）
出版日: 2022年12月01日
発行: Polaris Market Research
ページ情報: 英文 117 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の髄膜炎診断検査の市場規模は、2032年までに1億6,262万米ドルに達すると予測されています。

当レポートでは、世界の髄膜炎診断検査市場を調査しており、市場の概要、市場規模や予測、動向、促進要因・抑制要因、検査タイプ別・最終用途別・地域別などの分析、さらに企業プロファイルなどを提供しています。

目次

第1章 イントロダクション

  • レポートの説明
    • 調査の目的
    • 市場範囲
    • 前提条件
  • 利害関係者

第2章 エグゼクティブサマリー

  • 市場のハイライト

第3章 調査手法

  • 概要
    • データマイニング
  • 情報源
    • 一次情報
    • 二次情報

第4章 世界の髄膜炎診断検査市場の洞察

  • 髄膜炎診断検査市場 - 業界のスナップショット
  • 髄膜炎診断検査市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターのファイブフォース分析
    • 供給企業の交渉力
    • 新規参入者の脅威
    • 買い手の交渉力
    • 代替品の脅威
    • 既存企業間の競争力
  • PESTLE分析
  • 髄膜炎診断検査業界の動向
  • バリューチェーン分析
  • COVID-19影響分析

第5章 世界の髄膜炎診断検査市場：検査タイプ別

  • 主な調査結果
  • イントロダクション
    • 世界の髄膜炎診断検査、検査タイプ別（2019年～2032年）
  • ラテックス凝集試験
    • 世界の髄膜炎診断検査市場、ラテックス凝集試験別、地域別（2019年～2032年）
  • ラテラルフローアッセイ
    • 世界の髄膜炎診断検査市場、ラテラルフローアッセイ別、地域別（2019年～2032年）
  • PCRアッセイ
    • 世界の髄膜炎診断検査市場、PCRアッセイ別、地域別（2019年～2032年）
  • ELISA検査
    • 世界の髄膜炎診断検査市場、ELISA検査別、地域別（2019年～2032年）
  • 培養検査
    • 世界の髄膜炎診断検査市場、培養検査別、地域別（2019年～2032年）

第6章 世界の髄膜炎診断検査市場：最終用途別

  • 主な調査結果
  • イントロダクション
    • 世界の髄膜炎診断検査市場、最終用途別（2019年～2032年）
  • 病院
    • 世界の髄膜炎診断検査市場、病院別、地域別（2019年～2032年）
  • 診断センター
    • 世界の髄膜炎診断検査市場、診断センター別、地域別（2019年～2032年）
  • その他
    • 世界の髄膜炎診断検査市場、その他別、地域別（2019年～2032年）

第7章 世界の髄膜炎診断検査市場：地域別

  • 主な調査結果
  • イントロダクション
    • 髄膜炎診断検査市場の評価、地域別（2019年～2032年）
  • 髄膜炎診断検査市場 - 北米
    • 北米：髄膜炎診断検査市場、最終用途別（2019年～2032年）
    • 北米：髄膜炎診断検査市場、検査タイプ別（2019年～2032年）
    • 髄膜炎診断検査市場 - 米国
    • 髄膜炎診断検査市場 - カナダ
  • 髄膜炎診断検査市場 - 欧州
    • 欧州：髄膜炎診断検査市場、最終用途別（2019年～2032年）
    • 欧州：髄膜炎診断検査市場、検査タイプ別（2019年～2032年）
    • 髄膜炎診断検査市場 - 英国
    • 髄膜炎診断検査市場 - フランス
    • 髄膜炎診断検査市場 - ドイツ
    • 髄膜炎診断検査市場 - イタリア
    • 髄膜炎診断検査市場 - スペイン
    • 髄膜炎診断検査市場 - オランダ
    • 髄膜炎診断検査市場 - ロシア
  • 髄膜炎診断検査市場 - アジア太平洋
    • アジア太平洋：髄膜炎診断検査市場、最終用途別（2019年～2032年）
    • アジア太平洋：髄膜炎診断検査市場、検査タイプ別（2019年～2032年）
    • 髄膜炎診断検査市場 - 中国
    • 髄膜炎診断検査市場 - インド
    • 髄膜炎診断検査市場 - マレーシア
    • 髄膜炎診断検査市場 - 日本
    • 髄膜炎診断検査市場 - インドネシア
    • 髄膜炎診断検査市場 - 韓国
  • 髄膜炎診断検査市場 - 中東・アフリカ
    • 中東・アフリカ：髄膜炎診断検査市場、最終用途別（2019年～2032年）
    • 中東・アフリカ：髄膜炎診断検査市場、検査タイプ別（2019年～2032年）
    • 髄膜炎診断検査市場 - サウジアラビア
    • 髄膜炎診断検査市場 - アラブ首長国連邦
    • 髄膜炎診断検査市場 - イスラエル
    • 髄膜炎診断検査市場 - 南アフリカ
  • 髄膜炎診断検査市場 - ラテンアメリカ
    • ラテンアメリカ：髄膜炎診断検査市場、最終用途別（2019年～2032年）
    • ラテンアメリカ：髄膜炎診断検査市場、検査タイプ別（2019年～2032年）
    • 髄膜炎診断検査市場 - メキシコ
    • 髄膜炎診断検査市場 - ブラジル
    • 髄膜炎診断検査市場 - アルゼンチン

第8章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • パートナーシップ/コラボレーション/協定/公開

第9章 企業プロファイル

  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • ELITech Group
  • Abbott Laboratories
  • Becton
  • Dickinson and Company
  • Luminex Corporation
  • GlaxoSmithKline
  • Merck KGaA
  • Baxter Quest Diagnostics
  • F. Hoffman-La Roche
  • Cepheid
  • Pfizer
図表

List of Tables

  • Table 1 Global Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
  • Table 2 Global Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
  • Table 3 Meningitis Diagnostic Testing Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 4 North America: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
  • Table 5 North America: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
  • Table 6 U.S.: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
  • Table 7 U.S.: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
  • Table 8 Canada: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
  • Table 9 Canada: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
  • Table 10 Europe: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
  • Table 11 Europe: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
  • Table 12 UK: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
  • Table 13 UK: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
  • Table 14 France: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
  • Table 15 France: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
  • Table 16 Germany: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
  • Table 17 Germany: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
  • Table 18 Italy: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
  • Table 19 Italy: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
  • Table 20 Spain: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
  • Table 21 Spain: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
  • Table 22 Netherlands: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
  • Table 23 Netherlands: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
  • Table 24 Russia: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
  • Table 25 Russia: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
  • Table 26 Asia Pacific: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
  • Table 27 Asia Pacific: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
  • Table 28 China: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
  • Table 29 China: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
  • Table 30 India: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
  • Table 31 India: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
  • Table 32 Malaysia: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
  • Table 33 Malaysia: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
  • Table 34 Japan: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
  • Table 35 Japan: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
  • Table 36 Indonesia: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
  • Table 37 Indonesia: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
  • Table 38 South Korea: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
  • Table 39 South Korea: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
  • Table 40 Middle East & Africa: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
  • Table 41 Middle East & Africa: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
  • Table 42 Saudi Arabia: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
  • Table 43 Saudi Arabia: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
  • Table 44 UAE: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
  • Table 45 UAE: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
  • Table 46 Israel: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
  • Table 47 Israel: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
  • Table 48 South Africa: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
  • Table 49 South Africa: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
  • Table 50 Latin America: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
  • Table 51 Latin America: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
  • Table 52 Mexico: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
  • Table 53 Mexico: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
  • Table 54 Brazil: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
  • Table 55 Brazil: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
  • Table 56 Argentina: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
  • Table 57 Argentina: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)

List of Figures

Figure 1 Global Meningitis Diagnostic Testing Market, 2019-2032 (USD Million)

Figure 2 Integrated Ecosystem

Figure 3 Research Methodology: Top-Down & Bottom-Up Approach

Figure 4 Market by Geography

Figure 5 Porter's Five Forces

Figure 6 Market by End-Use

Figure 7 Global Meningitis Diagnostic Testing Market, by End-Use, 2021 & 2030 (USD Million)

Figure 8 Market by Test Type

Figure 9 Global Meningitis Diagnostic Testing Market, by Test Type, 2021 & 2030 (USD Million)

Figure 10 Meningitis Diagnostic Testing Market Assessment, By Geography, 2019-2032 (USD Million)

Figure 11 Strategic Analysis - Meningitis Diagnostic Testing Market

目次
Product Code: PM2957

The global meningitis diagnostic testing market size is expected to reach USD 162.62 million by 2032, according to a new study by Polaris Market Research. The report "Meningitis Diagnostic Testing Market Share, Size, Trends, Industry Analysis Report, By Test Type (Latex Agglutination Test, Lateral Flow Assay, PCR Assay, ELISA Test, Culture Test); By End-use; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Key factors influencing the market growth rise in the cases of meningitis in developed economies, upsurge in diagnostic centers, and patient's awareness regarding the severity of the disease. Moreover, emerging nations with viable options for treatment and a massive target population contribute to market growth. In line with this, in January 2021, Thermo Fisher Scientific signed a final agreement to buy Mesa Biotech, Inc., a privately held molecular diagnostic firm, for about $450 million to provide reliable testing solutions.

Around 375 instances of meningococcal infection were recorded in the U.S. In June 2021, according to the Center for Disease Control and Prevention Updates (an incidence rate of 0.11 cases per 100,000 persons). All these factors cumulatively affect the industry growth of this region in the forecast period.

Asia Pacific region is estimated to show the fastest growth rate in the forecast period for some key reasons, including the increasing prevalence of meningitis, continuous research initiatives, and developing economies. Additionally, continuing trials in the region, favorable regulatory efforts, and increased investments by regional market participants are expected to boost regional growth throughout the forecast period.

In June 2022, the Florida Department of Health and the Centers for Disease Control and Prevention (CDC) worked together to discover one of the worst meningococcal disease outbreaks among homosexual and bisexual men in American history. There have been at least 24 cases and six fatalities among homosexual and bisexual males recorded till that time. These outbreaks boosted the market's growth. The development of diagnostic tests which can detect meningitis in less time provides additional help in treating meningitis, leading to the growth of this industry.

Meningitis Diagnostic Testing Market Report Highlights

PCR Assay segment is anticipated to grow at the highest CAGR over the forecast period due to its rapid test findings that are highly exact and accurate; it has the most significant market revenue. This fast turnaround for results improved clinical outcomes for patient care.

The hospital sector is expected to hold a significant market share over the forecast period due to the availability of optimal care delivery and the severity of meningitis in patients.

North America is expected to grow significantly over the projected period because of an increase in the number of patients suffering from the disease.

Key players in the market include Thermo Fisher Scientific, Bio-Rad Laboratories, ELI TechGroup, Abbott Laboratories, Becton and Dickinson, Luminex Corporation, GlaxoSmithKline, Merck KGaA, Baxter Quest Diagnostics, Roche, Cepheid, Pfizer.

Polaris Market Research has segmented the meningitis diagnostic testing market report based on test type, end-use, and region:

Meningitis Diagnostic Testing, Test Types Outlook (Revenue - USD Million, 2019 - 2032)

Latex Agglutination Test

Lateral Flow Assay

PCR Assay

ELISA Test

Culture Test

Meningitis Diagnostic Testing, End-Use Outlook (Revenue - USD Million, 2019 - 2032)

Hospitals

Diagnostic Centers

Others

Meningitis Diagnostic Testing, Regional Outlook (Revenue - USD Million, 2019 - 2032)

North America

U.S

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Meningitis Diagnostic Testing Market Insights

  • 4.1. Meningitis Diagnostic Testing Market - Industry Snapshot
  • 4.2. Meningitis Diagnostic Testing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing prevalence of meningitis
      • 4.2.1.2. Rise in demand for rapid diagnosis by using innovative technologies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Stringent regulatory framework
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Meningitis Diagnostic Testing Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Meningitis Diagnostic Testing Market, by Test Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Meningitis Diagnostic Testing, by Test Type, 2019-2032 (USD Million)
  • 5.3. Latex Agglutination Tests
    • 5.3.1. Global Meningitis Diagnostic Testing Market, by Latex Agglutination Tests, by Region, 2019-2032 (USD Million)
  • 5.4. Lateral Flow Assay
    • 5.4.1. Global Meningitis Diagnostic Testing Market, by Lateral Flow Assay, by Region, 2019-2032 (USD Million)
  • 5.5. PCR Assay
    • 5.5.1. Global Meningitis Diagnostic Testing Market, by PCR Assay, by Region, 2019-2032 (USD Million)
  • 5.6. ELISA Tests
    • 5.6.1. Global Meningitis Diagnostic Testing Market, by ELISA Tests, by Region, 2019-2032 (USD Million)
  • 5.7. Culture Tests
    • 5.7.1. Global Meningitis Diagnostic Testing Market, by Culture Tests, by Region, 2019-2032 (USD Million)

6. Global Meningitis Diagnostic Testing Market, by End-Use

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
  • 6.3. Hospitals
    • 6.3.1. Global Meningitis Diagnostic Testing Market, by Hospitals, by Region, 2019-2032 (USD Million)
  • 6.4. Diagnostic Centers
    • 6.4.1. Global Meningitis Diagnostic Testing Market, by Diagnostic Centers, by Region, 2019-2032 (USD Million)
  • 6.5. Others
    • 6.5.1. Global Meningitis Diagnostic Testing Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Meningitis Diagnostic Testing Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Meningitis Diagnostic Testing Market Assessment, By Geography, 2019-2032 (USD Million)
  • 7.3. Meningitis Diagnostic Testing Market - North America
    • 7.3.1. North America: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
    • 7.3.2. North America: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
    • 7.3.3. Meningitis Diagnostic Testing Market - U.S.
      • 7.3.3.1. U.S.: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
      • 7.3.3.2. U.S.: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
    • 7.3.4. Meningitis Diagnostic Testing Market - Canada
      • 7.3.4.1. Canada: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
      • 7.3.4.2. Canada: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
  • 7.4. Meningitis Diagnostic Testing Market - Europe
    • 7.4.1. Europe: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
    • 7.4.2. Europe: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
    • 7.4.3. Meningitis Diagnostic Testing Market - UK
      • 7.4.3.1. UK: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
      • 7.4.3.2. UK: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
    • 7.4.4. Meningitis Diagnostic Testing Market - France
      • 7.4.4.1. France: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
      • 7.4.4.2. France: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
    • 7.4.5. Meningitis Diagnostic Testing Market - Germany
      • 7.4.5.1. Germany: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
      • 7.4.5.2. Germany: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
    • 7.4.6. Meningitis Diagnostic Testing Market - Italy
      • 7.4.6.1. Italy: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
      • 7.4.6.2. Italy: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
    • 7.4.7. Meningitis Diagnostic Testing Market - Spain
      • 7.4.7.1. Spain: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
      • 7.4.7.2. Spain: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
    • 7.4.8. Meningitis Diagnostic Testing Market - Netherlands
      • 7.4.8.1. Netherlands: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
      • 7.4.8.2. Netherlands: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
    • 7.4.9. Meningitis Diagnostic Testing Market - Russia
      • 7.4.9.1. Russia: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
      • 7.4.9.2. Russia: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
  • 7.5. Meningitis Diagnostic Testing Market - Asia Pacific
    • 7.5.1. Asia Pacific: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
    • 7.5.2. Asia Pacific: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
    • 7.5.3. Meningitis Diagnostic Testing Market - China
      • 7.5.3.1. China: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
      • 7.5.3.2. China: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
    • 7.5.4. Meningitis Diagnostic Testing Market - India
      • 7.5.4.1. India: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
      • 7.5.4.2. India: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
    • 7.5.5. Meningitis Diagnostic Testing Market - Malaysia
      • 7.5.5.1. Malaysia: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
      • 7.5.5.2. Malaysia: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
    • 7.5.6. Meningitis Diagnostic Testing Market - Japan
      • 7.5.6.1. Japan: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
      • 7.5.6.2. Japan: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
    • 7.5.7. Meningitis Diagnostic Testing Market - Indonesia
      • 7.5.7.1. Indonesia: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
      • 7.5.7.2. Indonesia: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
    • 7.5.8. Meningitis Diagnostic Testing Market - South Korea
      • 7.5.8.1. South Korea: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
      • 7.5.8.2. South Korea: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
  • 7.6. Meningitis Diagnostic Testing Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
    • 7.6.2. Middle East & Africa: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
    • 7.6.3. Meningitis Diagnostic Testing Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
      • 7.6.3.2. Saudi Arabia: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
    • 7.6.4. Meningitis Diagnostic Testing Market - UAE
      • 7.6.4.1. UAE: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
      • 7.6.4.2. UAE: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
    • 7.6.5. Meningitis Diagnostic Testing Market - Israel
      • 7.6.5.1. Israel: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
      • 7.6.5.2. Israel: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
    • 7.6.6. Meningitis Diagnostic Testing Market - South Africa
      • 7.6.6.1. South Africa: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
      • 7.6.6.2. South Africa: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
  • 7.7. Meningitis Diagnostic Testing Market - Latin America
    • 7.7.1. Latin America: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
    • 7.7.2. Latin America: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
    • 7.7.3. Meningitis Diagnostic Testing Market - Mexico
      • 7.7.3.1. Mexico: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
      • 7.7.3.2. Mexico: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
    • 7.7.4. Meningitis Diagnostic Testing Market - Brazil
      • 7.7.4.1. Brazil: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
      • 7.7.4.2. Brazil: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)
    • 7.7.5. Meningitis Diagnostic Testing Market - Argentina
      • 7.7.5.1. Argentina: Meningitis Diagnostic Testing Market, by End-Use, 2019-2032 (USD Million)
      • 7.7.5.2. Argentina: Meningitis Diagnostic Testing Market, by Test Type, 2019-2032 (USD Million)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Thermo Fisher Scientific
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Bio-Rad Laboratories
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. ELITech Group
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Abbott Laboratories
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Becton
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Dickinson and Company
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Luminex Corporation
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. GlaxoSmithKline
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Merck KGaA
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Baxter Quest Diagnostics
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. F. Hoffman-La Roche
    • 9.11.1. Company Overview
    • 9.11.2. Financial PerTest Typeance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development
  • 9.12. Cepheid
    • 9.12.1. Company Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Recent Development
  • 9.13. Pfizer
    • 9.13.1. Company Overview
    • 9.13.2. Financial Performance
    • 9.13.3. Product Benchmarking
    • 9.13.4. Recent Development